The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Anthelmin 230 mg/20 mg film-coated tablets for cats

230/20 mg/tablet Film-coated tablet

Krka, d.d., Novo mestoVPA10774/049/001

Main Information

Trade NameAnthelmin 230 mg/20 mg film-coated tablets for cats
Active SubstancesPyrantel embonate
Strength230/20 mg/tablet
Dosage FormFilm-coated tablet
Licence HolderKrka, d.d., Novo mesto
Licence NumberVPA10774/049/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
Therapeutic ClassAnthelmintic


Licence Issued31/03/2017
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back